Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
AUSTIN, Texas, May 15, 2013 /PRNewswire/ — Vermillion, Inc. (NASDAQ:VRML), a molecular diagnostics company focused on gynecologic cancers and women’s health, reported on its financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
